Boston biotech raises $109M to fuel platform for vaccines, crop protection
A biotechnology company headquartered in Boston is advancing its work on crop protection and developing vaccines for Covid-19 and shingles. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 23, 2022 Category: Biotechnology Authors: Zac Ezzone Source Type: news

RTP biotech raises $109M to fuel platform for vaccines, crop protection
A biotechnology company in Research Triangle Park is advancing its work on crop protection and developing vaccines for Covid-19 and shingles. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 23, 2022 Category: Biotechnology Authors: Zac Ezzone Source Type: news

What It Really Feels Like to Have Monkeypox
Since the global monkeypox outbreak began in May 2022, more than 22,000 cases have been confirmed in countries around the world. More than 5,000 of those cases have been recorded in the U.S., with many clustered in hotspots including New York and California. The virus, which often results in a blister-like rash and spreads through close contact, has so far predominantly affected men who have sex with men. Even as cases tick up and monkeypox gains public attention, however, it can still be difficult to find information about testing, treatment, and vaccines. Many people who fear they are at risk or infected are left to seek...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Jamie Ducharme, Angela Haupt and Jeffrey Kluger Tags: Uncategorized healthscienceclimate monkeypox Source Type: news

STELARA ® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, August 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). This rare disease that resembles adult PsA affects five to eight percent of children and adolescents with chronic inflammatory arthritis.*1-7 Two of the four indications for STELARA now include pediatric patients, further expanding its treatment profile since the first approval in 2009 for adults living with moderate...
Source: Johnson and Johnson - August 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

GSK raises profit guidance after strong sales of shingles vaccine
Quarterly figures beat expectations as pharma group strengthens pipeline of new drugs (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2022 Category: Pharmaceuticals Source Type: news

CDC Endorses Novavax COVID-19 Shot for Adults
U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax—a more traditional kind of vaccine, health officials said Tuesday. Regulators authorized the nation’s first so-called protein vaccine against COVID-19 last week, but the final hurdle was a recommendation from the Centers for Disease Control and Prevention. “If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” Dr. Rochelle Walensky, CDC’s director, said in a s...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Wisconsin SeniorCare Program to Cover Vaccines Provided at Pharmacies
Gov. Tony Evers and the Wisconsin Department of Health Services (DHS) announce Wisconsin ’s SeniorCare Program has received approval from the Centers for Medicare& Medicaid Services (CMS) to cover certain vaccines that members receive in pharmacies. Vaccines covered include those that protect against shingles, tetanus, meningitis, and Hepatitis A and B. These vaccines are recommended by theAdvisory Committee on Immunization Practices...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - June 27, 2022 Category: Hospital Management Authors: millejcodn Source Type: news

A Fourth COVID-19 Vaccine, From Novovax, Passed a Key Stage in the Authorization Process
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option. Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial va...
Source: TIME: Health - June 8, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

FDA Advisers Back a New COVID-19 Vaccine, Made By Novavax
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional technology than today’s U.S. options. Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company. FDA’s vaccine chief Dr. Peter Marks said another choice in the U....
Source: TIME: Health - June 7, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 wire Source Type: news

Monkeypox Is Not The Same As Shingles Despite Covid-19 Vaccine-Related Claims
There are now unfounded claims that the monkeypox outbreak is really a shingles outbreak due to Covid-19 vaccines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 27, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news

Why You Shouldn't Get the Shingles Vaccine
Title: Why You Shouldn ' t Get the Shingles VaccineCategory: Diseases and ConditionsCreated: 5/24/2022 12:00:00 AMLast Editorial Review: 5/24/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - May 24, 2022 Category: Dermatology Source Type: news

Shingles vaccination: eligibility poster, UKHSA (updated 11th May 2022)
Posters showing who is eligible for shingles vaccination for GP surgeries, hospitals, care homes and primary care settings. 11 May 2022Removed information relating to vaccinations during the COVID-19 lockdown. 27 April 2021Updated shingles vaccination eligibility information and poster. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 11, 2022 Category: Consumer Health News Source Type: news

World immunisation week – 24-30 April
This annual event is championed by the World Health Organisation (WHO) and promotes the use of vaccines to protect people of all ages against preventable diseases, ranging from pre-school vaccinations like MMR, to flu and shingles which are available to older age groups. (Source: NHS Networks)
Source: NHS Networks - April 22, 2022 Category: UK Health Source Type: news

Shingles Risk Increased For People Over 50 Who Had COVID, Study Says
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p25").init({"mcp":"cbs","width":"100%","height":"100%","video":"6228464","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p25","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5","customMetadata":{"vi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 20, 2022 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News COVID-19 Covid-19 Boston, MA Health Healthwatch Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Shingles Source Type: news